Kiernan A. Seth
Keine laufenden Positionen mehr
Vermögen: 127 526 $ am 31.03.2024
Profil
Kiernan A.
Seth worked as the Head of the Oncology Business Unit at Eisai, Inc. He then served as the Chief Commercial Officer & Vice President at Lexicon Pharmaceuticals, Inc. from 2021 to 2023.
Dr. Seth completed his undergraduate degree at Norfolk State University, followed by an MBA from St. Joseph's University.
He also obtained a doctorate from Meharry Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2023 | 53 136 ( 0,02% ) | 127 526 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Kiernan A. Seth
| Unternehmen | Position | Ende |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02.11.2023 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | - |
Ausbildung von Kiernan A. Seth
| Norfolk State University | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
| Meharry Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
